Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ATL001 |
Trade Name | |
Synonyms | ATL 001|ATL-001 |
Drug Descriptions |
ATL001 are personalized patient-derived tumor infiltrating lymphocytes that target tumor neoantigens, which may result in the induction of an antitumor immune response (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C171097 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ATL001 | ATL001 | 0 | 2 |
ATL001 + Nivolumab | ATL001 Nivolumab | 0 | 1 |
ATL001 + Pembrolizumab | ATL001 Pembrolizumab | 0 | 1 |